Morgan Stanley’s TetraLogic Pharmaceuticals TLOG Stock Holding History
Bought
Maintained
Sold
Other funds holding TLOG
Morgan Stanley's TLOG Position: Q4 2016 in Review
Morgan Stanley sold out of TetraLogic Pharmaceuticals (TLOG) in Q4 2016, closing a stake of 42,845 shares — an estimated $6K sold.
Morgan Stanley first reported a position in TLOG in Q4 2013 and held it in 12 quarters. The position peaked at $229K in Q1 2015. 3 funds tracked by Wall St. Rank hold TLOG as of Q4 2016.
- Morgan Stanley reported no remaining TetraLogic Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
- Morgan Stanley sold 42,845 TetraLogic Pharmaceuticals shares in Q4 2016, an estimated $6K.
- Morgan Stanley first reported a position in TetraLogic Pharmaceuticals in Q4 2013 and held it in 12 quarters.
- Morgan Stanley's TetraLogic Pharmaceuticals position peaked at $229K in Q1 2015.
- 3 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals as of Q4 2016.
Based on Morgan Stanley's 13F filing for Q4 2016, filed 13 Feb 2017.